Clinical Trial Update: Study of PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Male Chinese Subjects With Hemophilia A [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating PF-05208756 and Moroctocog alfa (AF-CC) with Xyntha in male Chinese subjects with Hemophilia A has completed and posted result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Moroctocog alfa AF-CC (moroctocog alfa)
• PF-05208756
• Xyntha (recombinant coagulation factor VIII)

Snippet

Sponsor: Pfizer | Conditions: Hemophilia A | Phase 1 | Status: COMPLETED | Results posted: 2016-06-15